Cargando…
SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair
BACKGROUND: Cisplatin is commonly used to treat cervical cancer while drug resistance limits its effectiveness. There is an urgent need to identify strategies that increase cisplatin sensitivity and improve the outcomes of chemotherapy. RESULTS: We performed whole exome sequencing (WES) of 156 cervi...
Autores principales: | Wang, Xin, Cao, Chen, Tan, Xiangyu, Liao, Xueyao, Du, Xiaofang, Wang, Xueqian, Liu, Ting, Gong, Danni, Hu, Zheng, Tian, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262521/ https://www.ncbi.nlm.nih.gov/pubmed/37308924 http://dx.doi.org/10.1186/s13578-023-01054-y |
Ejemplares similares
-
Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1
por: Tan, Xiangyu, et al.
Publicado: (2023) -
Roles for the methyltransferase SETD8 in DNA damage repair
por: Xu, Libo, et al.
Publicado: (2022) -
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations
por: Tomita, Sakura, et al.
Publicado: (2020) -
The dynamic conformational landscape of the protein methyltransferase SETD8
por: Chen, Shi, et al.
Publicado: (2019) -
Small-Molecule Inhibitors of SETD8 with Cellular Activity
por: Blum, Gil, et al.
Publicado: (2014)